| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/02/1993 | EP0369000A4 Macrocyclic complexes of yttrium, the lanthanides and the actinides having peripheral coupling functionalities |
| 06/02/1993 | CN1072681A 1.3-dihydro-2h-imidazo(4,5-6) quinolin-2-one derivatives. |
| 06/02/1993 | CN1021050C Preparing method for butyrumid derivative |
| 06/01/1993 | US5216133 Thermosensitive, trypsin, chymotrypsin and mercaptam sensitive, pure protein |
| 06/01/1993 | US5215964 Treating aging, depression, anxiety, autoimmune diseases |
| 06/01/1993 | US5215895 Dna encoding a mammalian cytokine, interleukin-11 |
| 06/01/1993 | CA1318686C Catechol derivatives, a process of preparation thereof, and therapeutical compositions containing the same |
| 06/01/1993 | CA1318673C 5-methoxy alkyl ammonium tetrahydrofurans and tetrahydrothiophenes |
| 06/01/1993 | CA1318670C 2-acyloxypropylamine derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| 06/01/1993 | CA1318666C Immunostimulating guanine derivatives, compositions and methods |
| 06/01/1993 | CA1318664C 16,17-acetalsubstituted pregnane 21-oic acid derivatives |
| 06/01/1993 | CA1318591C Composition containing heparin or derivative thereof |
| 05/27/1993 | WO1993010236A1 Protein allergens of the species cynodon dactylon |
| 05/27/1993 | WO1993010235A1 Human il-4 mutant proteins |
| 05/27/1993 | WO1993010229A1 Fusion proteins comprising mgf and il-3 |
| 05/27/1993 | WO1993010094A1 Novel substituted salicyclic acids |
| 05/27/1993 | WO1993010087A1 Derivatives of cyclic phenolic thioethers as inhibitors or stimulators of superoxide generation |
| 05/27/1993 | WO1993010073A1 Acyclic ethylenediamine derivatives as substance p receptor antagonists |
| 05/27/1993 | WO1993009815A1 Specific tolerance in transplantation |
| 05/27/1993 | WO1993009812A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 05/27/1993 | WO1993009811A1 TYPE I AND TYPE II SURFACE ANTIGENS ASSOCIATED WITH $i(STAPHYLOCOCCUS EPIDERMIDIS) |
| 05/27/1993 | WO1993009810A1 Mhc subunit conjugates useful in ameliorating deleterious immune responses |
| 05/27/1993 | WO1993009805A1 Polar lipid composition of plant origin |
| 05/27/1993 | WO1993009795A1 Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them |
| 05/27/1993 | WO1993009777A1 Tocotrienols and tocotrienol-like compounds and methods for their use |
| 05/27/1993 | WO1993006812A3 Use of an emulsion to prepare an intravenously administered medicament for treating skin diseases |
| 05/27/1993 | CA2378820A1 Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes |
| 05/27/1993 | CA2124086A1 Tocotrienols and tocotrienol-like compounds and methods for their use |
| 05/27/1993 | CA2123585A1 Polar lipidic composition from plants |
| 05/27/1993 | CA2123228A1 Mhc subunit conjugates useful in ameliorating deleterious immune responses |
| 05/27/1993 | CA2123210A1 Protein allergens of the species cynodon dactylon |
| 05/27/1993 | CA2120134A1 Derivatives of cyclic phenolic thioethers as inhibitors or stimulators of superoxide generation |
| 05/27/1993 | CA2117282A1 Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprosing them |
| 05/26/1993 | EP0543417A1 Tocotrienols and tocotrienol-like compounds and methods for their use |
| 05/26/1993 | EP0542971A1 CLONING AND RECOMBINANT PRODUCTION OF RECEPTOR(S) OF THE ACTIVIN/TGF-$g(b) SUPERFAMILY |
| 05/26/1993 | EP0542860A1 Immunosuppressive compositions |
| 05/26/1993 | EP0542795A1 Tnf inhibitors |
| 05/26/1993 | EP0532530A4 Derivatives of 6-aminooctahydroindolizinetriol |
| 05/26/1993 | EP0513150A4 New method for treating immunodeficiency or neutropenia |
| 05/26/1993 | CN1020906C Process for preparation of 2-(heterocyclylalkyl) imidazopyridines compounds |
| 05/26/1993 | CN1020893C Improved process for preparing vinyl ethers |
| 05/25/1993 | US5214040 Side effect reduction |
| 05/25/1993 | CA1318457C Partially retro-inverted tuftsin analogues, method for the preparation thereof and pharmaceutical compositions containing them |
| 05/25/1993 | CA1318456C Peptides |
| 05/19/1993 | EP0541753A1 NOVEL HYBRID, SOLUBLE AND UNCLEAVED gp160 VARIANT. |
| 05/19/1993 | EP0541706A1 Process and intermediate for the preparation of 2-hydroxy-3-sulfido-3-phenyl propanoic acids. |
| 05/19/1993 | EP0541701A1 INTERLEUKIN-4 AND INTERLEUKIN-1$g(b) SYNERGISTICALLY INDUCE VCAM-1 |
| 05/19/1993 | EP0541694A1 Method for treating immune system dysfunctions |
| 05/19/1993 | EP0541593A1 Cyclopentane derivatives, process for producing them and their pharmaceutical use. |
| 05/19/1993 | DE4137333A1 Therapeutische mittel, die antagonisten oder partielle agonisten des humanen interleukin 4 sind oder diese enthalten, hil-4-mutantenproteine sowie vefahren zu deren herstellung Therapeutic agents which are antagonists or partial agonists of human interleukin 4 are or contain hIL-4 mutant proteins as well as for their preparation vefahren |
| 05/18/1993 | US5212187 Pyridyl alkylamine compounds which are useful against histamine h1 and h2 receptors |
| 05/18/1993 | US5212160 Autoimmune disease, aging or bronchopulmonary disease |
| 05/18/1993 | US5212156 Srif-related peptides and uses thereof |
| 05/18/1993 | CA1317964C N-phenyl butenamides with pharmaceutical properties |
| 05/18/1993 | CA1317959C 5-(_-ammonio acyloxy methylene) tetrahydrofurans and tetrahydrothiophenes |
| 05/18/1993 | CA1317958C Substituted benzimidazoles and benzothidiazoles |
| 05/18/1993 | CA1317939C ¬(bicyclic heterocyclyl)methyl and -hetero| substituted hexahydro-1h-azepines and pyrrolidines |
| 05/15/1993 | CA2082562A1 The use of preparations of curcuma plants |
| 05/13/1993 | WO1993009234A2 Suppressor and progenitor cells |
| 05/13/1993 | WO1993009222A2 Transfection of vertebrate cells e.g. by homologous recombination |
| 05/13/1993 | WO1993009141A1 Antigen associated with type i diabetes mellitus |
| 05/13/1993 | WO1993009130A1 Materials comprising and methods of preparation and use for ribosome-inactivating proteins |
| 05/13/1993 | WO1993009118A1 1,3-dihydro-2h-imidazo(4,5-b)quinolin-2-one derivatives as phosphodiesterase inhibitors |
| 05/13/1993 | WO1993009093A1 Vitamin d amide derivatives |
| 05/13/1993 | WO1993008843A1 Trapped cells and use thereof as a drug |
| 05/13/1993 | WO1993008817A1 Cd8 binding domain peptides |
| 05/13/1993 | WO1993008816A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 05/13/1993 | WO1993008815A1 Pharmaceutical dipeptide compositions and methods of use thereof |
| 05/13/1993 | CA2124858A1 Suppressor and progenitor cells |
| 05/13/1993 | CA2122991A1 Transfection of vertebrate cells by homologous recombination |
| 05/13/1993 | CA2122359A1 Antigen associated with type i diabetes mellitus |
| 05/13/1993 | CA2122266A1 Cd8 binding domain peptides |
| 05/13/1993 | CA2122024A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 05/13/1993 | CA2099246A1 Trapped cells and use thereof as a drug |
| 05/12/1993 | EP0541214A2 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
| 05/12/1993 | EP0541153A1 1,3-Dihydro-2H-imidazo[4,5-b]-quinolin-2-one derivatives as phosphodiesterase inhibitors |
| 05/12/1993 | EP0541042A1 2,4- and 2,5-pyridine-dicarboxylic acid derivatives, process for their preparation and their use |
| 05/12/1993 | EP0540663A1 Interleukin 8 inhibition of cytokine-induced histamine release from bosophils or mast cells |
| 05/12/1993 | EP0540645A1 Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells |
| 05/12/1993 | EP0540599A1 Adoptive immunotherapy with interleukin-7 |
| 05/12/1993 | CN1071833A N-phenyl-2-cyano-3-hydroxy-crotonamide derivatives and use as immunoregulation druge |
| 05/11/1993 | US5210227 Derivatives of macrolide FR-900506, which had previously been isolated from Streptomyces microorganisms |
| 05/11/1993 | US5210078 Trifluoromethyl analogs of fucose and uses thereof |
| 05/11/1993 | US5210072 Immunomodulant, suppressing IgE formation |
| 05/11/1993 | CA1317595C Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as an active substance |
| 05/06/1993 | CA2082076A1 Pyridine-2,4 and -2,5-dicarboxamides and their derivatives, process for their preparation, and their use |
| 05/05/1993 | EP0540165A1 Alkanoic acid derivatives |
| 05/05/1993 | EP0540143A2 Compounds and methods for inhibition of HIV and related viruses |
| 05/05/1993 | EP0539748A1 Polypeptides capable of binding to heavy chains of IL-2 receptors |
| 05/05/1993 | EP0539525A1 Vitaletheine and use in cell culture and therapy |
| 05/05/1993 | EP0539455A1 Multivalent anti-cytokine immunoglobulins |
| 05/05/1993 | EP0539421A1 Novel oxazolyl derivatives |
| 05/05/1993 | EP0539420A1 Novel substituted thiazolyl and substituted pyridinyl derivatives |
| 05/05/1993 | EP0539418A1 Imidazopyridine paf antagonists |
| 05/05/1993 | EP0539372A1 Therapeutic agents |
| 05/05/1993 | EP0484512A4 Human peripheral blood cells in an immunocompromised host |
| 05/05/1993 | CN1071667A Phenothiazine quaternary ammonium derivative and process for preparing their composition |
| 05/05/1993 | CN1020473C Dna clones coding for polypeptides exhibiting human graulocyte macrophage and eosinophil cellular growth factor activity |
| 05/05/1993 | CN1020472C Mammalian interleukin-4 |
| 05/04/1993 | US5208321 Labeled antigens |